Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "High Potency API (HPAPI) Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering.
Significant Market Drivers and Growth Forecasted for HPAPI Contract Manufacturing
The global market for High Potency API (HPAPI) Contract Manufacturing is on the rise, with a valued projection at USD 7.15 billion in 2022. Looking ahead, substantial progress is foreseen with an estimated robust compound annual growth rate (CAGR) of 8.42% expected through 2028. Crucial for the development of targeted therapies, HPAPIs are pivotal compounds known for high pharmacological efficacy at minimal doses, addressing cancer, autoimmune diseases, and rare disorders.
Impact of Chronic and Rare Diseases on Market Dynamics
Chronic and rare diseases are driving market growth, calling for innovative and highly potent drug development. The Global HPAPI Contract Manufacturing Market thrives as it provides pharmaceutical companies with essential services that streamline drug development and achieve cost-efficiency. Patent expirations of blockbuster drugs further enhance the market prospects, as companies need to innovate and produce cost-effective alternative therapies promptly.
Cost and Technology: Key Challenges in HPAPI Contract Manufacturing
Specialized contract manufacturing organizations (CMOs) face the challenges of stringent regulatory compliance and the high costs associated with the necessary infrastructure and technology for HPAPI production. The evolving regulatory landscape and complexity in supply chain management also present significant hurdles. Nonetheless, CMOs continue to advance, adopting state-of-the-art technologies to maintain safety standards and pursue efficient production processes.
Oncology and Precision Medicine: Leading Forces in the HPAPI Market
With oncology treatments increasing in demand due to a global rise in cancer cases, HPAPI-based medications are more sought-after than ever. Precision medicine is also at the forefront, focusing on developing customized, targeted treatments that often necessitate the use of HPAPIs. North America currently dominates the market, with significant contributions due to a strong pharmaceutical industry and concentrated oncology research.
Market Outlook and Regional Insights
The market is also marked by segmental insights, with injectables and oncology emerging as dominant sectors in the global HPAPI market in 2022. The North American region, particularly the United States, leads the charge, benefiting from its mature pharmaceutical sector and ongoing advancements in cancer treatments. The competitive landscape is expected to evolve with ongoing technological improvements and strategic collaborations among key players.
The HPAPI Contract Manufacturing Market displays strong potential, promising innovations, and significant advancements, bolstering its stature within the pharmaceutical and biotech industries globally. For detailed market insights and further information on this robustly growing market sector, industry professionals and stakeholders continue to monitor the developments within the HPAPI Contract Manufacturing landscape.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 190 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value (USD) in 2022 | $7.15 Billion |
| Forecasted Market Value (USD) by 2028 | $11.48 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes, but is not limited to:
- Catalent, Inc.
- Lonza Group
- Piramal Pharma Solutions
- Pfizer CentreOne
- Gentec Pharmaceutical Group
- AbbVie Contract Manufacturing
- Corden Pharma International
- Curia Global, Inc.
- Merck Group (SigmaAldrich Co., LLC)
- Polpharma Group
For more information about this report visit https://www.researchandmarkets.com/r/577viu
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
